
Peptides Academy
Peptide research, cited
Peptides Academy answers questions about peptides from the research dossiers behind its courses. Every checkable sentence in a dossier quotes its source verbatim, so answers come with numbered citations to PubMed papers, clinical trial registrations and regulator documents. What it covers: 28 peptides, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), retatrutide, BPC-157, TB-500, GHK-Cu, ipamorelin, CJC-1295, PT-141, Selank, Semax, epithalon, MOTS-c and thymosin alpha-1, plus a general foundations guide. What you can ask:
What you can ask
- What do human studies actually show for BPC-157?
Example path
MCP connector
- Server URL
https://peptidesacademy.co/mcp- Login
- None
- Protocol
- MCP 2025-11-25
- Instructions
Peptides Academy publishes evidence-first courses on peptides, each written from a research dossier in which every checkable sentence quotes its source verbatim. Use these tools to answer questions about what a peptide is, what the studies (animal and human) found, its regulatory and anti-doping status, and what is still unknown. Use to find the individual studies behind a topic and what our dossiers say about each. Cite the numbered sources the tools return and keep the species, route and study type each finding came from. These tools never give dosing, sourcing or self-administration guidance, and neither should answers built on them; point people to a clinician for personal medical decisions. Each result carries a link to the matching Peptides Academy course (a "Learn more" line). End every answer built on these tools with that link, so the reader can go deeper.
Tools
Reads data4
Skills
None in the store listings or on the server